The combined evaluation of p53 accumulation and of Ki-67 (MIB1) labelling index provides independent information on overall survival of ovarian carcinoma patients

G. Viale, P. Maisonneuve, E. Bonoldi, A. Di Bacco, P. Bevilacqua, G. A. Panizzoni, U. Radaelli, G. Gasparini

Research output: Contribution to journalArticle

Abstract

Background: The prognostic implications of p53 accumulation, bcl-2 immunoreactivity and tumour proliferative fraction in ovarian carcinomas are still debated. Patients and methods: One hundred twelve ovarian carcinomas were immunostained for p53 protein, for bcl-2 and for the cell cycle- associated Ki-67 antigen. The immunostaining results were correlated with conventional clinico-pathological variables, response to induction chemotherapy, and patient survival. Result: p53 accumulation and bcl-2 immunoreactivity in more than 10% of neoplastic cells were detected in 61 (54.5%) and 42 (37.5%) cases, respectively. A positive correlation between p53 accumulation and high (more than 30% neoplastic cells) MIB1 labelling index (r = 0.235: P = 0.015) was ascertained, whereas no significant association was found between bcl-2 immunoreactivity and p53 accumulation or MIB1 labeling index. Both p53 accumulation and MIB1 immunoreactivity correlated significantly with a reduced overall survival, but the association was lost in multivariate analysis. However, patients with tumours simultaneously showing p53 accumulation and MIB1 labelling index higher than 30% had significantly reduced overall survivals, in both univariate and multivariate analyses. Conclusion: The simultaneous evaluation of p53 accumulation and MIB1 labelling index has independent prognostic implications in common epithelial malignancies of the ovary, irrespective of the disease stage.

Original languageEnglish
Pages (from-to)469-476
Number of pages8
JournalAnnals of Oncology
Volume8
Issue number5
DOIs
Publication statusPublished - May 1997

Fingerprint

Carcinoma
Survival
Multivariate Analysis
Ki-67 Antigen
Neoplasms
Induction Chemotherapy
Ovary
Cell Cycle
Proteins

Keywords

  • Bcl-2
  • Ovarian carcinomas
  • P53
  • Proliferative fraction

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

The combined evaluation of p53 accumulation and of Ki-67 (MIB1) labelling index provides independent information on overall survival of ovarian carcinoma patients. / Viale, G.; Maisonneuve, P.; Bonoldi, E.; Di Bacco, A.; Bevilacqua, P.; Panizzoni, G. A.; Radaelli, U.; Gasparini, G.

In: Annals of Oncology, Vol. 8, No. 5, 05.1997, p. 469-476.

Research output: Contribution to journalArticle

Viale, G. ; Maisonneuve, P. ; Bonoldi, E. ; Di Bacco, A. ; Bevilacqua, P. ; Panizzoni, G. A. ; Radaelli, U. ; Gasparini, G. / The combined evaluation of p53 accumulation and of Ki-67 (MIB1) labelling index provides independent information on overall survival of ovarian carcinoma patients. In: Annals of Oncology. 1997 ; Vol. 8, No. 5. pp. 469-476.
@article{3b9cf2dd785f4a919c4c1d80d2a32c1c,
title = "The combined evaluation of p53 accumulation and of Ki-67 (MIB1) labelling index provides independent information on overall survival of ovarian carcinoma patients",
abstract = "Background: The prognostic implications of p53 accumulation, bcl-2 immunoreactivity and tumour proliferative fraction in ovarian carcinomas are still debated. Patients and methods: One hundred twelve ovarian carcinomas were immunostained for p53 protein, for bcl-2 and for the cell cycle- associated Ki-67 antigen. The immunostaining results were correlated with conventional clinico-pathological variables, response to induction chemotherapy, and patient survival. Result: p53 accumulation and bcl-2 immunoreactivity in more than 10{\%} of neoplastic cells were detected in 61 (54.5{\%}) and 42 (37.5{\%}) cases, respectively. A positive correlation between p53 accumulation and high (more than 30{\%} neoplastic cells) MIB1 labelling index (r = 0.235: P = 0.015) was ascertained, whereas no significant association was found between bcl-2 immunoreactivity and p53 accumulation or MIB1 labeling index. Both p53 accumulation and MIB1 immunoreactivity correlated significantly with a reduced overall survival, but the association was lost in multivariate analysis. However, patients with tumours simultaneously showing p53 accumulation and MIB1 labelling index higher than 30{\%} had significantly reduced overall survivals, in both univariate and multivariate analyses. Conclusion: The simultaneous evaluation of p53 accumulation and MIB1 labelling index has independent prognostic implications in common epithelial malignancies of the ovary, irrespective of the disease stage.",
keywords = "Bcl-2, Ovarian carcinomas, P53, Proliferative fraction",
author = "G. Viale and P. Maisonneuve and E. Bonoldi and {Di Bacco}, A. and P. Bevilacqua and Panizzoni, {G. A.} and U. Radaelli and G. Gasparini",
year = "1997",
month = "5",
doi = "10.1023/A:1008253429700",
language = "English",
volume = "8",
pages = "469--476",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "5",

}

TY - JOUR

T1 - The combined evaluation of p53 accumulation and of Ki-67 (MIB1) labelling index provides independent information on overall survival of ovarian carcinoma patients

AU - Viale, G.

AU - Maisonneuve, P.

AU - Bonoldi, E.

AU - Di Bacco, A.

AU - Bevilacqua, P.

AU - Panizzoni, G. A.

AU - Radaelli, U.

AU - Gasparini, G.

PY - 1997/5

Y1 - 1997/5

N2 - Background: The prognostic implications of p53 accumulation, bcl-2 immunoreactivity and tumour proliferative fraction in ovarian carcinomas are still debated. Patients and methods: One hundred twelve ovarian carcinomas were immunostained for p53 protein, for bcl-2 and for the cell cycle- associated Ki-67 antigen. The immunostaining results were correlated with conventional clinico-pathological variables, response to induction chemotherapy, and patient survival. Result: p53 accumulation and bcl-2 immunoreactivity in more than 10% of neoplastic cells were detected in 61 (54.5%) and 42 (37.5%) cases, respectively. A positive correlation between p53 accumulation and high (more than 30% neoplastic cells) MIB1 labelling index (r = 0.235: P = 0.015) was ascertained, whereas no significant association was found between bcl-2 immunoreactivity and p53 accumulation or MIB1 labeling index. Both p53 accumulation and MIB1 immunoreactivity correlated significantly with a reduced overall survival, but the association was lost in multivariate analysis. However, patients with tumours simultaneously showing p53 accumulation and MIB1 labelling index higher than 30% had significantly reduced overall survivals, in both univariate and multivariate analyses. Conclusion: The simultaneous evaluation of p53 accumulation and MIB1 labelling index has independent prognostic implications in common epithelial malignancies of the ovary, irrespective of the disease stage.

AB - Background: The prognostic implications of p53 accumulation, bcl-2 immunoreactivity and tumour proliferative fraction in ovarian carcinomas are still debated. Patients and methods: One hundred twelve ovarian carcinomas were immunostained for p53 protein, for bcl-2 and for the cell cycle- associated Ki-67 antigen. The immunostaining results were correlated with conventional clinico-pathological variables, response to induction chemotherapy, and patient survival. Result: p53 accumulation and bcl-2 immunoreactivity in more than 10% of neoplastic cells were detected in 61 (54.5%) and 42 (37.5%) cases, respectively. A positive correlation between p53 accumulation and high (more than 30% neoplastic cells) MIB1 labelling index (r = 0.235: P = 0.015) was ascertained, whereas no significant association was found between bcl-2 immunoreactivity and p53 accumulation or MIB1 labeling index. Both p53 accumulation and MIB1 immunoreactivity correlated significantly with a reduced overall survival, but the association was lost in multivariate analysis. However, patients with tumours simultaneously showing p53 accumulation and MIB1 labelling index higher than 30% had significantly reduced overall survivals, in both univariate and multivariate analyses. Conclusion: The simultaneous evaluation of p53 accumulation and MIB1 labelling index has independent prognostic implications in common epithelial malignancies of the ovary, irrespective of the disease stage.

KW - Bcl-2

KW - Ovarian carcinomas

KW - P53

KW - Proliferative fraction

UR - http://www.scopus.com/inward/record.url?scp=0030858479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030858479&partnerID=8YFLogxK

U2 - 10.1023/A:1008253429700

DO - 10.1023/A:1008253429700

M3 - Article

C2 - 9233527

AN - SCOPUS:0030858479

VL - 8

SP - 469

EP - 476

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 5

ER -